The threat of antimicrobial resistance in developing countries: causes and control strategies
- PMID: 28515903
- PMCID: PMC5433038
- DOI: 10.1186/s13756-017-0208-x
The threat of antimicrobial resistance in developing countries: causes and control strategies
Abstract
The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients' behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.
Keywords: Antimicrobial therapy; Developing countries; Microorganisms; Resistance.
Similar articles
-
Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review.Int J Antimicrob Agents. 2018 Dec;52(6):771-782. doi: 10.1016/j.ijantimicag.2018.09.022. Epub 2018 Oct 9. Int J Antimicrob Agents. 2018. PMID: 30312654
-
The role of Environmental Health in preventing antimicrobial resistance in low- and middle-income countries.Environ Health Prev Med. 2021 Oct 5;26(1):100. doi: 10.1186/s12199-021-01023-2. Environ Health Prev Med. 2021. PMID: 34610785 Free PMC article.
-
Antimicrobial self medication in patients attending a sexually transmitted diseases clinic.Int J STD AIDS. 1997 Jul;8(7):456-8. doi: 10.1258/0956462971920343. Int J STD AIDS. 1997. PMID: 9228594
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Drivers of inappropriate antibiotic use in low- and middle-income countries.JAC Antimicrob Resist. 2023 May 31;5(3):dlad062. doi: 10.1093/jacamr/dlad062. eCollection 2023 Jun. JAC Antimicrob Resist. 2023. PMID: 37265987 Free PMC article. Review.
Cited by
-
The application of medical ethics in the developing countries - A neurosurgical perspective.Brain Spine. 2024 Oct 12;4:103921. doi: 10.1016/j.bas.2024.103921. eCollection 2024. Brain Spine. 2024. PMID: 39493952 Free PMC article. Review.
-
Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study.Antimicrob Resist Infect Control. 2024 Sep 4;13(1):98. doi: 10.1186/s13756-024-01439-9. Antimicrob Resist Infect Control. 2024. PMID: 39227975 Free PMC article.
-
Antibiotic resistance risk assessment in Mymensingh, Bangladesh: Current scenario from human-animal-environmental interfaces viewpoint.Heliyon. 2024 Aug 6;10(15):e35878. doi: 10.1016/j.heliyon.2024.e35878. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170164 Free PMC article.
-
Multidrug-Resistant, Including Extended-Spectrum Beta Lactamase-Producing and Quinolone-Resistant, Escherichia coli Isolated from Poultry and Domestic Pigs in Dar es Salaam, Tanzania.Antibiotics (Basel). 2021 Apr 9;10(4):406. doi: 10.3390/antibiotics10040406. Antibiotics (Basel). 2021. PMID: 33918543 Free PMC article.
-
First report of carbapenems encoding multidrug-resistant gram-negative bacteria from a pediatric hospital in Gaza Strip, Palestine.BMC Microbiol. 2024 Oct 9;24(1):393. doi: 10.1186/s12866-024-03550-8. BMC Microbiol. 2024. PMID: 39379824 Free PMC article.
References
-
- Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect. Dis. 2005;5:568–580. - PubMed
-
- Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis. 2005;5:481–493. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical